☆ 4.1 Article

Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2021)

Related references

Note: Only part of the references are listed.

Article Allergy

Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections

Qing Lei et al.

Summary: The study found that combining nucleic acid testing with serological testing significantly increases the detection sensitivity of asymptomatic infections. Asymptomatic individuals mainly produce IgM and IgG antibodies against S1 and N proteins, with S1-specific IgM antibodies potentially serving as early diagnostic biomarkers. Some asymptomatic individuals do not produce neutralizing antibodies, and these antibodies gradually disappear within two months.

ALLERGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda et al.

Summary: The study found that individuals recovered from mild COVID-19 develop sustained SARS-CoV-2-specific immunological memory for at least 3 months, including immunoglobulin antibodies, neutralizing plasma, and memory B and T cells. These memory lymphocytes exhibit potent antiviral function, aiding in immune defense.

CELL (2021)

Add to Collection

Article Health Care Sciences & Services

Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020

Harvey W. Kaufman et al.

Summary: Serologic tests for SARS-CoV-2 can identify immune response which varies based on age, sex, and duration since exposure. Adults may infect household children.

POPULATION HEALTH MANAGEMENT (2021)

Add to Collection

Article Immunology

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Katharine H. D. Crawford et al.

Summary: Antibody levels, including neutralizing antibodies, decline after SARS-CoV-2 infection, with a 4-fold average decrease in titers from 1 to 4 months after symptom onset. This decline is accompanied by a decrease in total antibodies capable of binding the viral spike protein. Further studies are needed to determine the long-term durability of immunity to SARS-CoV-2, including examination of long-lived B cells and antibody titers over extended periods.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Interpreting Diagnostic Tests for SARS-CoV-2

Nandini Sethuraman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Spread of SARS-CoV-2 in the Icelandic Population

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil

Mariangela F. Silveira et al.

NATURE MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Hematology

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma

Latha Dulipsingh et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

Add to Collection

Article Microbiology

A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients

Yuxin Chen et al.

PLOS PATHOGENS (2020)

Add to Collection

Article Biology

Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset

Benny Borremans et al.

ELIFE (2020)

Add to Collection

Article Virology

Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect

Gabriel N. Maine et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020

Wesley H. Self et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Public, Environmental & Occupational Health

SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys

Pedro C. Hallal et al.

LANCET GLOBAL HEALTH (2020)

Add to Collection

Article Immunology

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

Baweleta Isho et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Heterogeneity and longevity of antibody memory to viruses and vaccines

Alice Antia et al.

PLOS BIOLOGY (2018)

Add to Collection

Article Immunology

Duration of antibody responses after severe acute respiratory syndrome

Li-Ping Wu et al.

EMERGING INFECTIOUS DISEASES (2007)

Add to Collection

Letter Medicine, General & Internal

Disappearance of antibodies to SARS-associated coronavirus after recovery

Wu-Chun Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Add to Collection

Article Biotechnology & Applied Microbiology

Prevalence of antibodies to Vaccinia virus after smallpox vaccination In Italy

MM Pütz et al.

JOURNAL OF GENERAL VIROLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.